|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities | ||||
| Depreciation and amortization | ||||
| Change in valuation of contingent consideration liability | ||||
| Payment of contingent consideration in excess of acquisition date fair value | ||||
| Change in fair value of warrant liabilities | ||||
| Stock compensation expense | ||||
| Provision for expected credit losses | ||||
| Deferred income taxes | ||||
| Inventory write-down | ||||
| Loss on disposal of property, plant, and equipment | ||||
| Cloud computing arrangements development costs | ||||
| Interest expense, related party | ||||
| Other, net | ||||
| Changes in current assets and liabilities: | ||||
| Accounts receivable, net | ||||
| Accounts receivable from related party | ||||
| Inventories | ||||
| Other current assets | ||||
| Accounts payable and accrued liabilities | ||||
| Accounts payable to related party | ||||
| Net cash used by operating activities | ||||
| Cash flows from investing activities: | ||||
| Capital expenditures | ||||
| Net cash used by investing activities | ||||
| Cash flows from financing activities: | ||||
| Borrowings under term loan - related party (Note 15) | ||||
| Repayment on notes payable to related party (Note 16) | ||||
| Net proceeds from the Business Combination and PIPE Investments (Note 4) | ||||
| Payment of contingent consideration up to acquisition date fair value | ||||
| Transfers from Parent (Note 16) | ||||
| Gross proceeds from the sale of common stock pursuant to the at-the-market public offering (Note 1) | ||||
| Payment of offering costs from the at-the-market public offering (Note 1) | ||||
| Repurchase of common stock | ||||
| Proceeds received from exercise of warrants (Note 6) | ||||
| Net cash provided (used) by financing activities | ||||
| Cash and cash equivalents: | ||||
| Cash and cash equivalents—beginning of period | ||||
| Net increase (decrease) in cash and cash equivalents | ||||
| Cash and cash equivalents—end of period | ||||
| Effect of exchange rate changes on cash and cash equivalents |
Loading...